As the ER signaling pathway is considered a potential target for therapy in a subset of HGSC, the most common histological subtype of ovarian cancer, reliable markers to identify this anti-estrogen sensitive subset are needed. The gene discussed is ESR1; the disease is ovarian carcinoma.